C Buchanan

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi request reprint A retrospective analysis of ezetimibe treatment in renal transplant recipients
    C Buchanan
    University of Utah Hospitals and Clinics, Renal Transplant Program, Salt Lake City, Utah, USA
    Am J Transplant 6:770-4. 2006

Detail Information

Publications1

  1. ncbi request reprint A retrospective analysis of ezetimibe treatment in renal transplant recipients
    C Buchanan
    University of Utah Hospitals and Clinics, Renal Transplant Program, Salt Lake City, Utah, USA
    Am J Transplant 6:770-4. 2006
    ..8% after 3.1 months of therapy. Ezetimibe as combination or monotherapy is a safe and effective treatment option for dyslipidemia in renal transplant recipients without changes in calcineurin inhibitor levels or renal function...